 | |
- close
- close
StreetInsider.com
7 hrs ago
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Equity+Offerings/Sinovac+%28SVA%29+Prices+11.5M+Shares+at+%245.75Share+for+Net+Proceeds+of+%2462M/5292885.html for the full story.
PR Newswire
7 hrs ago
Comment
BEIJING, Feb. 1 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq: SVA) ("Sinovac" or the "Company"), a leading China-based vaccine manufacturer, announced today that the underwriters of its previously announced public common share offering have
StreetInsider.com
Jan 28
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Equity+Offerings/Sinovac+Biotech+%28SVA%29+Prices+10M+Common+Offering+at+%245.75Share/5283235.html for the full story.
StreetInsider.com
Jan 20
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Equity+Offerings/Sinovac+Biotech+%28SVA%29+To+Offer+8.65M+Shares/5262285.html for the full story.
StreetInsider.com
Jan 20
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Guidance/Sinovac+%28SVA%29+Raises+FY09+Sales+Outlook+to+%2481-%2485M%3B+Comments+on+Possible+Acquisition/5261926.html for the full story.
PR Newswire
Jan 20
Comment
BEIJING, Jan. 20 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq: SVA) ("Sinovac" or the "Company"), a leading China-based vaccine manufacturer, today announced the following recent developments. Dalian Joint Venture In November 2009, Sinovac,
PR Newswire
Jan 14
Comment
In the news release, "Sinovac Obtains Fifth H1N1 Vaccine Order from Chinese Central Government," issued earlier today by Sinovac Biotech Ltd. over PR Newswire, we are advised by the company that the first sentence of the second paragraph should
StreetInsider.com
Jan 13
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Sinovac+Biotech+%28SVA%29+Receives+Fifth+Order+for+H1N1+Vaccine%2C+PANFLU.1%2C+from+Chinese+Ministry+of+IIT/5243973.html for the full story.
Market Intelligence Center
Jan 11
Comment
Sinovac Biotech (SVA) leads the list of top gainers so far today and is now at $7.45, up $0.78 (11.69%) on volume of 2,045,056 shares traded. Over the last 52 weeks the stock has ranged from a low of $1.02 to a high of $12.50. Sinovac Biotech...
Market Intelligence Center
Dec 28
Comment
Sinovac Biotech (NASDAQ: SVA) opened at $6.70. So far today, the stock has hit a low of $6.51 and a high of $6.76. SVA is now trading at $6.66, up $0.41 (6.56%). Over the last 52 weeks the stock has ranged from a low of $1.02 to a high of $12.50....
Suggest other news sources for this topic
Thank you for your suggestion
more ▼WIKI ANALYSIS
WIKI ANALYSIS
 |
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article. |
SVA AT A GLANCE
References
| ||||||
|
|
